AMICUS THERAPEUTICS INC (FOLD)

US03152W1099 - Common Stock

10.84  +0.02 (+0.18%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
399.36M329.20M305.50M260.90M182.20M
Cost Of Goods
37.33M38.60M34.50M31.00M22.00M
Gross Profit
362.03M290.60M271.00M229.80M160.30M
Operating Expenses
438.11M496.20M477.40M476.90M464.30M
Research and Development
152.38M276.70M272.00M308.40M286.40M
Selling, General, and Administrative Expenses
275.27M213.00M192.70M156.40M169.90M
Operating Income
-76.08M-205.50M-206.40M-247.00M-304.10M
Interest Income/Expense
-43.07M-34.10M-32.00M-19.20M-8.60M
Other Income/Expense
-15.89M4.20M-2.90M-800.00K-2.60M
Non Recurring Items
-15.07M-6.60M-300.00K-7.30M-40.60M
Income Before Taxes
-150.10M-242.00M-241.60M-274.30M-355.90M
Income Tax
1.48M-5.50M8.90M2.60M500.00K
Net Income
-151.58M-236.60M-250.50M-276.90M-356.40M
EBITDA
-68.20M-200.16M-200.19M-238.15M-299.32M
 
Per Share Data
EPS Diluted Total Ops
-0.51-0.82-0.92-1.07-1.48
Non GAAP EPS
-0.51-0.82-0.92-1.04-1.34
 
Statistics
Gross Profit Margin
90.65%88.27%88.71%88.08%87.98%
Profit Margin
-37.96%-71.87%-82.00%-106.13%-195.61%
Operating Profit Margin
-19.05%-62.42%-67.56%-94.67%-166.90%

All data in USD

Charts